Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Parsons Corporation is currently managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to FERNANDEZ, SUSAN EMILY, who is the busiest examiner for the company. The prosecution profile is highly focused, with only a solitary distinct examiner and a lone distinct art unit involved. This specific administrative group indicates that the company's current technical focus is situated within a niche of the biotechnology sector. The active office action is the only matter currently pending for the company.
FERNANDEZ, SUSAN EMILY is responsible for 1 pending office action, which constitutes the entirety of the company's current workload at the USPTO. With only one distinct examiner, the company can concentrate its efforts on addressing the specific concerns of a single individual. The active case represents the company's current path toward securing intellectual property in the Biotechnology & Pharmaceuticals field. Because there is only a single distinct art unit and one distinct examiner, the prosecution environment is straightforward and lacks the administrative complexity of larger portfolios. This 1 pending office action is the central element of the company's current patent strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FERNANDEZ, SUSAN EMILY | 1 | 52.5% | +60.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18679622 | SYSTEM AND METHOD FOR METHANE BIODEGRADATION | FERNANDEZ, SUSAN EMILY | 26d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18679622 | SYSTEM AND METHOD FOR METHANE BIODEGRADATION | FERNANDEZ, SUSAN EMILY | 26d |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18679622 | SYSTEM AND METHOD FOR METHANE BIODEGRADATION | FERNANDEZ, SUSAN EMILY | 1651 | §103§112 | Non-Final OA | 26d | Pending | May 31, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial